Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5766034 | 0.91 | MMP8 (0.51) | MMP8TSHRALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL271585 | 0.90 | MMP8 (0.59) | MMP8TSHRALDH1A1MAPK1TDP1 | |
| SCHEMBL5766030 | 0.89 | ALDH1A1 (0.53) | MMP8TSHRALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL11623145 | 0.85 | MMP8 (0.49) | MMP8TSHRALDH1A1L3MBTL1NPC1 | |
| SCHEMBL27354703 | 0.85 | MMP8 (0.49) | MMP8TSHRALDH1A1NPC1MEN1 | |
| SCHEMBL6841594 | 0.85 | MMP8 (0.49) | MMP8TSHRALDH1A1L3MBTL1NPC1 | |
| SCHEMBL4068942 | 0.84 | MMP8 (0.54) | MMP8TSHRALDH1A1NPC1MEN1 | |
| SCHEMBL11646519 | 0.84 | PTGS2 (0.54) | TSHRAKR1C3AKR1C2ESR1 | |
| SCHEMBL9391853 | 0.84 | POLB (0.49) | MMP8TSHRALDH1A1NPC1MEN1 | |
| SCHEMBL8429803 | 0.83 | AKR1C3 (0.46) | TSHRALDH1A1L3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109896684-A | A kind of pre-treating process for sewage in organic products preparation process | 李德祥 | 2019-06-18 | — | — | CN | claimed |
| US-20250312504-A1 | VOLATILE COMPOSITION DISPENSER FOR COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | THE PROCTER & GAMBLE COMPANY | 2025-10-09 | — | — | US | disclosed |
| US-20240199997-A1 | COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | PROCTER & GAMBLE COMPANY, THE | 2024-06-20 | — | — | US | disclosed |
| CN-207862238-U | A kind of Primidone reduction reaction device | 精华制药集团南通有限公司 | 2018-09-14 | — | — | CN | disclosed |
| CN-207862237-U | A kind of Primidone reduction apparatus with integrated hole flowmeter | 精华制药集团南通有限公司 | 2018-09-14 | — | — | CN | disclosed |
| US-20180186721-A1 | OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2018-07-05 | — | — | US | disclosed |
| CN-204675849-U | A kind of sewage pretreatment device for primidone synthesis | JINGHUA PHARMACEUTICAL GROUP NANTONG CO LTD | 2015-09-30 | — | — | CN | disclosed |
| CN-204672104-U | A kind of falling film absorbing device for absorbing hydrogen sulphide waste gas | JINGHUA PHARMACEUTICAL GROUP NANTONG CO LTD | 2015-09-30 | — | — | CN | disclosed |
| US-6759103-B2 | NEMATIC, CHOLESTERIC OR CHIRAL SMECTIC LIQUID-CRYSTAL MIXTURES HAVING HIGH ABSOLUTE DIELECTRIC ANISOTROPY VALUES AND WITH A FAVORABLE VISCOSITY/CLEARING POINT RELATIONSHIP; PHOTOSTABILITY; HEAT AND ULTRAVIOLET RADIATION RESISTANCE | CLARIANT FINANCI (BVI) LIMITED (VG) | 2004-07-06 | — | — | US | disclosed |
| CN-1121906-C | Long-lived homogenous oxidation catalyst | UNIV CARNEGIE MELLON (US) | 2003-09-24 | — | — | CN | disclosed |
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | CLARIANT INTERNATIONAL LTD. | 2003-05-15 | — | — | US | disclosed |
| CN-1230903-A | Long-lived homogenous oxidation catalyst | UNIV CARNEGIE MELLON (US) | 1999-10-06 | — | — | CN | disclosed |
| EP-0510526-B1 | Use of sulfonamides as drug and new sulfonamides | HOFFMANN LA ROCHE (CH) | 1996-12-04 | — | — | EP | disclosed |
| EP-0510526-A1 | Use of sulfonamides as drug and new sulfonamides | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1992-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180186721-A1 | OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS | SOD1, AOC3, CBR3 | MMP8 4481/4885TSHR 3443/4885ALDH1A1 862/4885 |
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | SCO2, CNOT1, HCFC1 | MMP8 3654/4885TSHR 4788/4885ALDH1A1 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.